http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014124267-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc408585f6863d7865c90ab9a4632135
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
filingDate 2014-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ae9b82abbe997970f4d2419c4a86b0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09bf83f71eb41d7e4442cfbee1310c89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d99c520d03607e2df3758882cb11b7e2
publicationDate 2014-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2014124267-A1
titleOfInvention Method for diagnosis, prognosis and determination of treatment for cutaneous t-cell lymphoma
abstract The present invention relates to biomarkers associated with CTCL, including TOX, PLS3, KIR3DL2, GATA3 and RUNX3, where increased expression, relative to normal control, of one or more of TOX, PLS3, KIR3DL2, and/or GATA3 is associated with CTCL and decreased expression of RUNX3, relative to normal control, is associated with CTCL. One or more of these biomarkers may be used to diagnose CTCL and/or design and monitor treatment.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3029151-A1
priorityDate 2013-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012064081-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010035971-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006271309-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1343822-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396322
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410872
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40461270
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID275196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396379
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148121
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396389
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400055
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4640
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57469
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6442177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396535
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408756

Total number of triples: 59.